Looking at the filing, this is a Form 10-Q for The Joint Corp. for the quarterly period ended September 30, 2026, filed on November 6, 2026. The filing text provided is primarily the cover page, table of contents, and forward-looking statements section. Let me assess the substantive disclosure content. The substantive content includes: share count (13,689,211 shares as of November 2, 2026), filing classification (non-accelerated filer, smaller reporting company), the registered securities table (JYNT on Nasdaq), and the forward-looking statements disclosures which contain some substantive business descriptions. This exceeds 150 words of substantive content. The ticker shown in the registered securities table is JYNT on "The Nasdaq Stock Market LLC" - so NASDAQ:JYNT.

The Joint Corp. filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the fiscal quarter ended September 30, 2026, disclosing 13,689,211 shares of common stock outstanding as of November 2, 2026.

Key Highlights

  • Shares outstanding: As of November 2, 2026, the registrant had 13,689,211 shares of common stock ($0.001 par value) outstanding.
  • Filer classification: The company is classified as a non-accelerated filer and a smaller reporting company, according to the filing.
  • Refranchising plan: The filing describes a plan "to refranchise or sell the full portfolio of our company-owned or managed clinics" to drive long-term growth.
  • Liquidity statement: The company expressed a belief that "existing cash and cash equivalents, our anticipated cash flows from operations and amounts available under our line of credit will be sufficient to fund our anticipated operating and investment needs for at least the next 12 months."
  • Macroeconomic outlook: The filing states the company anticipates "that 2026 will continue to be a volatile macroeconomic environment."

The Joint Corp. Quarterly Disclosure: Refranchising Strategy and Operating Context for Q3 2026

The Joint Corp. (NASDAQ:JYNT), a Scottsdale, Arizona-based operator and franchisor of chiropractic clinics, filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 6, 2026. The filing identifies the company as a non-accelerated filer and smaller reporting company under SEC rules, with 13,689,211 shares of common stock outstanding as of November 2, 2026.

According to the filing, the company's stated strategic direction centers on a "franchised-focused expansion of chiropractic clinics in key markets throughout North America, and potentially abroad." A refined strategy described in the filing is a plan "to refranchise or sell the full portfolio of our company-owned or managed clinics," which the company characterized as leveraging its "capacity to build a franchise - to drive long-term growth for both our franchisees and The Joint as a public company." The filing also describes an intent to "leverage the power of the regional developer program to accelerate the number of clinics sold, and eventually opened, across the country."

The filing notes several factors the company believes may impact operating results, including "the timing of new clinic sales, openings, closures, markets in which they are contained and related expenses, general economic conditions, cost inflation, labor shortages, elevated gas prices, consumer confidence in the economy, consumer preferences, competitive factors, and disease epidemics and other health-related concerns." The company disclosed a goal "to generate significant proceeds" that could be allocated to brand marketing, IT platforms, repurchase of regional development territories, merger or acquisition opportunities, and additional stock repurchase programs. All forward-looking statements in the filing are the company's own and are subject to its cautionary language regarding risks and uncertainties.

What Was Disclosed

The Joint Corp. submitted a Form 10-Q for Q3 2026, disclosing 13,689,211 shares outstanding as of November 2, 2026, its non-accelerated filer status, a refranchising strategy for company-owned clinics, and a liquidity belief covering at least the next 12 months.